Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003633 |
---|---|
Receipt number | R000001884 |
Scientific Title | Phase 1/2 Study of Docetaxel, CDDP and 5-FU therapy in Patients With Unresectable or Recurrent Esophageal Cancer |
Date of disclosure of the study information | 2010/05/18 |
Last modified on | 2019/05/26 11:21:28 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/05/18 20:41:59 | ||
2 | Update | 2010/05/18 21:07:14 | Institute Institute |
|
3 | Update | 2010/09/16 16:08:07 | Recruitment status |
|
4 | Update | 2010/11/21 09:48:19 | Name of person sending information Organization Division name Address |
|
5 | Update | 2011/11/20 09:06:34 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
6 | Update | 2014/05/20 18:00:12 | Email |
|
7 | Update | 2018/11/25 09:40:51 | Name of primary person or sponsor Organization |
|
8 | Update | 2019/05/26 11:21:28 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Organization Organization Address Address Tel |